Back
Plus Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison
Sell
21
PSTV
Plus Therapeutics
Last Price:
1.80
Seasonality Move:
-12.69%
Sell
30
CATX
Perspective Therapeutics
Last Price:
12.54
Seasonality Move:
-10.27%
Sell
21
Plus Therapeutics (PSTV)
is a Sell
Is Plus Therapeutics a Buy, Sell or Hold?
- The current Plus Therapeutics [PSTV] share price is $1.85. The Score for PSTV is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- PSTV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $12.57. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PSTV Stock Price Chart
What is Plus Therapeutics's stock price today?
-
The Plus Therapeutics share price today is $1.85
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PSTV is experiencing buying pressure, which is a positive indicator for future bullish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $12.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.
PSTV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 67.97 | Buy |
| Chaikin Money Flow: | 199360 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.35 - 1.61) | Buy |
| Bollinger Bands (100): | (1.45 - 2.09) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.52 | Sell |
| Relative Strength Index (14 RSI): | 39.77 | Sell |
| Chaikin Money Flow: | -64266 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.01 - 15.73) | Sell |
| Bollinger Bands (100): | (11.41 - 15.47) | Sell |
PSTV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.61 | Buy |
| 20-day SMA: | 1.5 | Buy |
| 50-day SMA: | 1.55 | Buy |
| 200-day SMA: | 1.83 | Buy |
| 8-day EMA: | 1.61 | Buy |
| 20-day EMA: | 1.55 | Buy |
| 50-day EMA: | 1.57 | Buy |
| 200-day EMA: | 1.93 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.69 | Sell |
| 20-day SMA: | 14.08 | Sell |
| 50-day SMA: | 13.75 | Sell |
| 200-day SMA: | 11.57 | Buy |
| 8-day EMA: | 12.79 | Sell |
| 20-day EMA: | 13.53 | Sell |
| 50-day EMA: | 13.63 | Sell |
| 200-day EMA: | 11.56 | Buy |
Plus Therapeutics Earnings Growth & PSTV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.61 per share, an increase next quarter of $0.02 per share, an increase this year of $2.64 per share, and an increase next year of $0.17 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.04 per share.
Plus Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||